{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:37:37Z","timestamp":1780555057639,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ijpharm.2004.09.025","type":"journal-article","created":{"date-parts":[[2004,12,29]],"date-time":"2004-12-29T05:14:09Z","timestamp":1104297249000},"page":"227-233","source":"Crossref","is-referenced-by-count":32,"title":["Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin"],"prefix":"10.1016","volume":"288","author":[{"given":"K.","family":"Higaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chomchan","family":"Amnuaikit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ogawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2004.09.025_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02442852","article-title":"In vivo evaluation of signal processors for laser Doppler tissue flowmeters","volume":"25","author":"Ahn","year":"1987","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000210917","article-title":"Importance of blood flow to the local distribution of drugs after percutaneous absorption in the bipediculated dorsal flap of the hairless rat","volume":"4","author":"Auclair","year":"1991","journal-title":"Skin Pharmacol."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib4","series-title":"Pharmaceutics: The Science of Dosage Form Design","first-page":"499","article-title":"Transdermal drug delivery","author":"Barry","year":"2002"},{"key":"10.1016\/j.ijpharm.2004.09.025_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/clpt.1992.134","article-title":"Intravenous nicotine retards transdermal absorption of nicotine: evidence of flood flow-limited percutaneous absorption","volume":"52","author":"Benowitz","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib6","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","first-page":"331","article-title":"Local anesthetics","author":"Catterall","year":"1995"},{"key":"10.1016\/j.ijpharm.2004.09.025_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(05)63324-7","article-title":"Is there tissue penetration after application of topical salicylate formulations?","volume":"350","author":"Cross","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2004.09.025_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF00542502","article-title":"The disposition of biphenylacetic acid following topical application","volume":"33","author":"Dawson","year":"1988","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(02)00084-4","article-title":"Estimation of intradermal disposition kinetics of drugs. Part II. Factors determining penetration of drugs from viable skin to muscular layer","volume":"239","author":"Higaki","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00137696-200301030-00004","article-title":"Strategies for overcoming stratum corneum: chemical and physical approaches","volume":"1","author":"Higaki","year":"2003","journal-title":"Am. J. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib11","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","first-page":"199","article-title":"Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists","author":"Hoffman","year":"1995"},{"key":"10.1016\/j.ijpharm.2004.09.025_bib12","series-title":"Percutaneous Absorption: Mechanisms, Methodology, Drug Delivery","first-page":"511","article-title":"Percutaneous penetration as a method of delivery to muscle and other tissues","author":"Marty","year":"1989"},{"key":"10.1016\/j.ijpharm.2004.09.025_bib13","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1023\/A:1015854728278","article-title":"Local enhanced topical delivery (LETD) of drugs: does it truly exist?","volume":"9","author":"McNeill","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archotol.1991.01870140048004","article-title":"Vasoconstrictors in facial plastic surgery","volume":"117","author":"Millay","year":"1991","journal-title":"Arch. Otolaryngol."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1018973814456","article-title":"Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature","volume":"10","author":"M-Riviere","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1023\/A:1018844928818","article-title":"Estimation of intradermal disposition kinetics of drugs. Part I. Analysis by compartment model with contralateral tissues","volume":"16","author":"Nakayama","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF02442104","article-title":"Signal processor for laser Doppler tissue flowmeters","volume":"22","author":"Nilsson","year":"1984","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1991.tb05576.x","article-title":"Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease","volume":"31","author":"Radermacher","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01061687","article-title":"Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application","volume":"21","author":"Singh","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2004.09.025_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/jop.1989.5.127","article-title":"Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol","volume":"5","author":"Urtti","year":"1989","journal-title":"J. Ocul. Pharmacol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304005885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517304005885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T14:57:32Z","timestamp":1548860252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517304005885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0378517304005885"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2004.09.025","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}